IDEXX Laboratories Inc (IX1.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 03:32PM CEST. Market open.
| Previous close | 456.40 |
| Open | 456.60 |
| Bid | 456.60 x 100000 |
| Ask | 459.60 x 100000 |
| Day's range | 456.70 - 457.70 |
| 52-week range | 365.90 - 536.80 |
| Volume | |
| Avg. volume | 5 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireIDEXX Laboratories to Release 2024 Second Quarter Financial Results
WESTBROOK, Maine, June 24, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day.
Simply Wall St.With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
ZacksIDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.
© 2024 Yahoo. All rights reserved.